Cite
[Short-term efficacy of dapagliflozin in children with hereditary proteinuric kidney disease].
MLA
Cui, J. Y., et al. “[Short-Term Efficacy of Dapagliflozin in Children with Hereditary Proteinuric Kidney Disease].” Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics, vol. 61, no. 2, Feb. 2023, pp. 164–68. EBSCOhost, https://doi.org/10.3760/cma.j.cn112140-20220711-00637.
APA
Cui, J. Y., Liu, J. J., Fang, X. Y., Chen, J., Zhai, Y. H., Xu, H., & Shen, Q. (2023). [Short-term efficacy of dapagliflozin in children with hereditary proteinuric kidney disease]. Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics, 61(2), 164–168. https://doi.org/10.3760/cma.j.cn112140-20220711-00637
Chicago
Cui, J Y, J J Liu, X Y Fang, J Chen, Y H Zhai, H Xu, and Q Shen. 2023. “[Short-Term Efficacy of Dapagliflozin in Children with Hereditary Proteinuric Kidney Disease].” Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics 61 (2): 164–68. doi:10.3760/cma.j.cn112140-20220711-00637.